Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of dual antiplatelet therapy in high-risk patients with acute coronary syndromes.

The Journal of family practice·2016
Same author

Practice pearl: the effect of canagliflozin on HbA1c and blood pressure in patients with type 2 diabetes mellitus.

Postgraduate medicine·2015
Same author

Emerging data on the incidence of concussion in football practice at all levels of amateur play.

The Physician and sportsmedicine·2015
Same author

Clinical use of dipeptidyl peptidase-4 and sodium-glucose cotransporter 2 inhibitors in combination therapy for type 2 diabetes mellitus.

Postgraduate medicine·2015
Same author

Review of: effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis.

The Physician and sportsmedicine·2013
Same author

Sodium-glucose co-transporter 2 inhibitors and the potential for cardiovascular risk reduction in patients with type 2 diabetes mellitus.

Postgraduate medicine·2013

Related Experiment Video

Updated: Jun 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Reshaping the dyslipidemia management paradigm.

Robert M Guthrie1

  • 1The Ohio State University College of Medicine and Public Health, Columbus, OH 43212, USA.

Postgraduate Medicine
|August 12, 2009
PubMed
Summary
This summary is machine-generated.

Identifying patients with lipid abnormalities and providing effective lipid-modifying therapy is crucial for reducing coronary heart disease (CHD) risk. Many patients do not receive aggressive enough treatment, necessitating improved cholesterol-lowering therapy and lifestyle changes.

Related Experiment Videos

Last Updated: Jun 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Extensive evidence supports lipid management for reducing coronary heart disease (CHD) risk.
  • Increasing prevalence of obesity, diabetes, and impaired fasting glucose contributes to rising CHD risk.
  • Current lipid-modifying therapies are often underdosed or insufficient for many at-risk patients.

Purpose of the Study:

  • To emphasize the importance of aggressive lipid management in preventing CHD.
  • To highlight the growing need for effective CHD risk reduction strategies in primary care.
  • To advocate for appropriate dosing of cholesterol-lowering therapy and lifestyle interventions.

Main Methods:

  • Review of existing evidence on lipid abnormalities and CHD risk.
  • Analysis of population trends impacting CHD risk (aging, obesity, diabetes).
  • Clinical recommendations for primary care physicians.

Main Results:

  • Lipid abnormalities are significant risk factors for CHD.
  • Therapeutic lifestyle changes and appropriate lipid-modifying therapy are essential.
  • Primary care physicians face increasing numbers of at-risk patients.

Conclusions:

  • Aggressive lipid-lowering therapy is imperative for effective CHD risk reduction.
  • Therapeutic lifestyle changes should be strongly encouraged alongside medication.
  • Primary care must adapt to manage a growing population at risk for cardiovascular events.